OpenAlex
PricingAboutJobs
Log inGet started
Work

Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

HTML

Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(15)61252-1
Authors: Sotirios Tsimikas, Nicholas J Viney, Steven G Hughes, Walter Singleton, Mark J Graham, Brenda F Baker, Jennifer L Burkey, Qingqing Yang, Santica M Marcovina, Richard S Geary, Rosanne M Crooke, Joseph L Witztum
Institutions: Ionis Pharmaceuticals (United States), University of California San Diego, University of Washington
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: apolipoprotein(a), lipoprotein(a), antisense therapy, cardiovascular risk, calcific aortic stenosis, pharmacokinetics, pharmacodynamics, safety and tolerability, dose escalation, complement system, healthy volunteers, lipid profile
SDG: Good health and well-being

Open Access status: closed

Funder: National Heart, Lung, and Blood Institute
Award: Role of Immune Mechanisms in Athersclerosis and Inflammation
OpenAlex ID: W1708837772
FWCI: 38.06
Cites: 35
Cited by: 482
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security